We conducted experiments to clarify the gain and loss of functions using a stable LY6K-transfected BC cell line and found that LY6K might have an oncogenic function, suggesting that it is a promising candidate for molecular targeting of human BC. The gene discussed is LY6K; the disease is breast cancer.